moderna - Search News

News

Moderna sharpens focus on $1.5bn cost cutting plan

Moderna lays off 500 in latest cost-cutting move

The layoffs are part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine business.

Reuters on MSN · 1d

Moderna plans to lay off 10% of workforce to cut costs

Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of the year, as the biotech accelerates its cost-cutting efforts amid declining sales of COVID-19 vaccines.

Fast Company on MSN · 1d

Moderna is laying off 10% of its workforce. Does RFK Jr. have anything to do with it?

Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees today.

Moderna Logs Sales Beat

The Wall Street Journal on MSN · 18h

Moderna Logs Sales Beat Despite Declining Vaccine Demand

Moderna’s second-quarter sales fell less sharply than Wall Street expected as it works to expand its offerings amid weakening demand for its Covid-19 vaccine.

Fierce Pharma · 14h

Despite ongoing decline, Moderna's Spikevax sales beat expectations in Q2

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which came in above the company’s expectations thanks to a “stronger-than-expected U.S. spring booster season,” CFO Jamey Mock said on an analyst call Friday.

Boston 25 News on MSN · 1d

Mass.-based Moderna slashing workforce amid declining COVID vaccine sales

Massachusetts-based Moderna announced Thursday that it plans to slash the size of its global workforce by about 10% in the coming months as COVID vaccine sales continue to decline. In a memo that was shared companywide,

18hon MSN

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...

13h

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

11h

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

Moderna Announces Data to be Presented at ESMO Congress 2025

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

13h

Stock Movers: Figma, Moderna, Coinbase

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

12hon MSN

Moderna cuts sales forecast on UK revenue delay, shares fall

Moderna trimmed its 2025 revenue forecast on Friday after UK deliveries of some COVID vaccines were deferred to next year, ...

Zacks.com on MSN5h

Here's What Key Metrics Tell Us About Moderna (MRNA) Q2 Earnings

Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street ...

Moderna, Inc. (MRNA) Stock forecasts

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Moderna sharpens focus on $1.5bn cost cutting plan

Moderna Logs Sales Beat

Related topics